DK1108424T3 - Matrix tablet for long-term release of - Google Patents

Matrix tablet for long-term release of

Info

Publication number
DK1108424T3
DK1108424T3 DK00403533T DK00403533T DK1108424T3 DK 1108424 T3 DK1108424 T3 DK 1108424T3 DK 00403533 T DK00403533 T DK 00403533T DK 00403533 T DK00403533 T DK 00403533T DK 1108424 T3 DK1108424 T3 DK 1108424T3
Authority
DK
Denmark
Prior art keywords
long
matrix tablet
term release
tablet
release
Prior art date
Application number
DK00403533T
Other languages
Danish (da)
Other versions
DK1108424T4 (en
Inventor
Patrick Wuthrich
De Barochez Bruno Huet
Claude Dauphant
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1108424(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1108424T3 publication Critical patent/DK1108424T3/en
Publication of DK1108424T4 publication Critical patent/DK1108424T4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00403533.3T 1999-12-17 2000-12-15 Matrix tablet for prolonged release of trimetazidine after oral administration. DK1108424T4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915960A FR2802424B1 (en) 1999-12-17 1999-12-17 MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION
EP00403533.3A EP1108424B2 (en) 1999-12-17 2000-12-15 Matrix tablet for sustained release of trimetazidine after oral administration

Publications (2)

Publication Number Publication Date
DK1108424T3 true DK1108424T3 (en) 2005-10-03
DK1108424T4 DK1108424T4 (en) 2013-12-16

Family

ID=9553398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00403533.3T DK1108424T4 (en) 1999-12-17 2000-12-15 Matrix tablet for prolonged release of trimetazidine after oral administration.

Country Status (33)

Country Link
EP (1) EP1108424B2 (en)
JP (2) JP2001172181A (en)
KR (1) KR100456933B1 (en)
CN (1) CN1166408C (en)
AR (1) AR026968A1 (en)
AT (1) ATE296622T1 (en)
AU (1) AU780011B2 (en)
BG (1) BG65773B1 (en)
BR (1) BR0005915A (en)
CY (1) CY2347B1 (en)
CZ (1) CZ299461B6 (en)
DE (1) DE60020501T3 (en)
DK (1) DK1108424T4 (en)
EA (2) EA008223B1 (en)
ES (2) ES2240033T5 (en)
FR (1) FR2802424B1 (en)
GE (1) GEP20053540B (en)
GR (1) GR1003658B (en)
HK (1) HK1036937A1 (en)
HU (1) HU226956B1 (en)
IE (1) IE20001017A1 (en)
IT (1) IT1317075B1 (en)
LU (1) LU90700B1 (en)
MX (1) MXPA00012462A (en)
NZ (1) NZ508912A (en)
OA (1) OA12121A (en)
PL (1) PL206994B1 (en)
PT (2) PT1108424E (en)
SI (1) SI1108424T2 (en)
SK (1) SK286752B6 (en)
UA (1) UA80087C2 (en)
WO (1) WO2001043747A1 (en)
ZA (1) ZA200007548B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442852T1 (en) * 2000-10-05 2009-10-15 Usv Ltd DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
KR101175816B1 (en) * 2003-08-04 2012-08-24 교린 세이야꾸 가부시키 가이샤 Sustained release tablet for oral use
SG126792A1 (en) * 2005-04-27 2006-11-29 Servier Lab Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
FR2885807B1 (en) * 2005-05-18 2008-05-16 Mg Pharma SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
CZ300307B6 (en) * 2006-01-04 2009-04-15 Zentiva, A. S. Modified release tablet containing trimetazidine or pharmacologically acceptable salts thereof
EA009776B1 (en) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Method for preparing tablets of dihydrochloride trimethazine and composition thereof
EA009810B1 (en) * 2006-12-26 2008-04-28 Закрытое Акционерное Общество "Канонфарма Продакшн" Matrix for manufacturing tableted dosage form and method of treatment
EP2200591A2 (en) * 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
JP2012515757A (en) 2009-01-20 2012-07-12 マイクロ ラブス リミテッド Trimetazidine controlled release solid pharmaceutical composition and method for producing the same
HUE027498T2 (en) * 2009-01-30 2016-10-28 Lupin Ltd Pharmaceutical compositions of trimetazidine
TR201001902A2 (en) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
RU2445958C2 (en) * 2010-04-20 2012-03-27 Общество с ограниченной ответственностью "Озон" (ООО "Озон") Matrix tablet with trimetazidine prolonged-release base and method for preparing it
ES2508490T3 (en) 2010-05-04 2014-10-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Formulation of trimetazidine with different release profiles
EP2386302A1 (en) 2010-05-11 2011-11-16 Ranbaxy Laboratories Limited A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof
EP2491930A1 (en) 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
FR2978916B1 (en) * 2011-08-10 2013-07-26 Servier Lab SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN
FR2986431B1 (en) * 2012-02-03 2017-03-17 Servier Lab PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS
CN102824644B (en) * 2012-09-13 2013-12-25 浙江诚意药业有限公司 High-stability sustained-release tablet prepared by using hydroxy propyl cellulose
KR20160118733A (en) 2015-04-03 2016-10-12 이인현 Hose guide apparatus for hose winder and hose winder
CN109316455B (en) * 2017-07-31 2021-05-25 北京福元医药股份有限公司 Trimetazidine hydrochloride sustained release tablet
CN109908096A (en) * 2017-12-12 2019-06-21 武汉武药科技有限公司 A kind of trimetazidine hydrochloride sustained-release tablets and preparation method thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
FR2490963B1 (en) * 1980-09-30 1986-04-18 Science Union & Cie NOVEL THERAPEUTIC COMPOSITION WITH ANTI-ISCHEMIC ACTION CONTAINING TRIMETHOXY 2, 3, 4-BENZYL 1-PIPERAZINE
KR850006132A (en) * 1984-02-29 1985-10-02 진 크라메르, 한스 루돌프 하우스 Bromocriptine Composition
JPS61293931A (en) * 1985-06-24 1986-12-24 Teijin Ltd Slow-releasing pharmaceutical composition
JPH0625055B2 (en) * 1985-03-18 1994-04-06 日本ケミフア株式会社 Persistent tablets
EP0207638B1 (en) † 1985-06-04 1990-12-19 Teijin Limited Sustained-release pharmaceutical preparation
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
SE8601624D0 (en) * 1986-04-11 1986-04-11 Haessle Ab NEW PHARMACEUTICAL PREPARATIONS
FR2677886B1 (en) * 1991-06-18 1995-03-31 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF INDAPAMIDE AFTER ORAL ADMINISTRATION.
FR2681324B1 (en) * 1991-09-18 1993-10-29 Adir Cie NOVEL TRIMETAZIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR940021051A (en) * 1993-03-03 1994-10-17 손정삼 3-step drug release sustained tablet
RU2082400C1 (en) * 1993-12-16 1997-06-27 Акционерное общество - Фармацевтическая фирма "Ник-Фарм" Method of nitroglycerol prolonged action preparing
FR2717687B1 (en) * 1994-03-24 1996-06-14 Adir Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.

Also Published As

Publication number Publication date
ITRM20000667A0 (en) 2000-12-14
HUP0004966A2 (en) 2002-06-29
FR2802424A1 (en) 2001-06-22
KR20010062478A (en) 2001-07-07
EP1108424A1 (en) 2001-06-20
HU0004966D0 (en) 2001-02-28
IE20001017A1 (en) 2002-04-03
PT102542A (en) 2001-06-29
DE60020501T2 (en) 2006-04-27
NZ508912A (en) 2002-04-26
EA008223B1 (en) 2007-04-27
SK8632002A3 (en) 2002-10-08
WO2001043747A1 (en) 2001-06-21
CN1166408C (en) 2004-09-15
EA200001201A3 (en) 2001-10-22
ES2240033T5 (en) 2014-01-16
PL206994B1 (en) 2010-10-29
JP2001172181A (en) 2001-06-26
EA200501901A1 (en) 2006-06-30
SI1108424T2 (en) 2014-02-28
EP1108424B2 (en) 2013-09-04
HU226956B1 (en) 2010-03-29
ES2240033T3 (en) 2005-10-16
ATE296622T1 (en) 2005-06-15
ITRM20000667A1 (en) 2002-06-14
IT1317075B1 (en) 2003-05-26
DK1108424T4 (en) 2013-12-16
KR100456933B1 (en) 2004-11-10
ZA200007548B (en) 2001-06-19
ES2176106A1 (en) 2002-11-16
EA200001201A2 (en) 2001-08-27
JP2007314578A (en) 2007-12-06
ES2176106B1 (en) 2004-01-16
CN1302663A (en) 2001-07-11
GEP20053540B (en) 2005-06-10
CZ299461B6 (en) 2008-08-06
DE60020501T3 (en) 2014-03-20
MXPA00012462A (en) 2002-06-04
AU780011B2 (en) 2005-02-24
AU7228500A (en) 2001-06-21
UA80087C2 (en) 2007-08-27
PL344564A1 (en) 2001-06-18
BG106927A (en) 2003-05-30
PT1108424E (en) 2005-08-31
CZ20022082A3 (en) 2002-09-11
BR0005915A (en) 2001-10-02
GR1003658B (en) 2001-09-05
DE60020501D1 (en) 2005-07-07
SI1108424T1 (en) 2005-10-31
WO2001043747A8 (en) 2001-09-07
AR026968A1 (en) 2003-03-05
SK286752B6 (en) 2009-04-06
CY2347B1 (en) 2004-06-04
HK1036937A1 (en) 2002-01-25
OA12121A (en) 2003-10-20
LU90700B1 (en) 2007-12-03
EP1108424B1 (en) 2005-06-01
HUP0004966A3 (en) 2008-04-28
FR2802424B1 (en) 2002-02-15
BG65773B1 (en) 2009-11-30

Similar Documents

Publication Publication Date Title
DK1108424T3 (en) Matrix tablet for long-term release of
EE200100134A (en) Quick release tablet
DE60013812D1 (en) QUICK RELEASE
DE60038784D1 (en) QUICK RELEASE
DK1095605T3 (en) Capsule ejection device
DK1105104T3 (en) Buccal bioadhesive tablet with long-term release
FI4823U1 (en) Modified release drug formulation
DK1147083T3 (en) Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
DK1274407T3 (en) Use of PPAR gamma agonists for neutrophil-induced diseases
DE60014641D1 (en) HYDRAULIC SETTING DEVICE
IS6070A (en) Variety of Bacillus Pumilus for the management of plant diseases
NO20021540L (en) Controlled release compositions comprising nimesulfide
AR027907A1 (en) COMPOSITION OF CONTROLLED RELEASE
DE60021839D1 (en) gradient lens
EE05024B1 (en) Oral gliclazide sustained release matrix tablet
PT1086701E (en) COMPOSITION LAXANT CONTAINING SIMETICONE
DK1275397T3 (en) Local drug
DK1061039T3 (en) Hydrogen production device
DK1218096T3 (en) Variable release microcapsules
DK1096549T3 (en) Substrate holding devices
DE60122229D1 (en) release film
DE60032726D1 (en) OPTICAL TIME RANGE REFERENCES
DE60225154D1 (en) NEW SELF-AUTHORIZING MEDICAMENT RELEASE SYSTEM
DK1158963T3 (en) Controlled Release Betahistine Compositions
DK1465602T3 (en) Matrix film tablet with controlled release of natural mixtures of conjugated estrogens